Background Cognitive impairment is frequent in lacunar stroke patients. The prevalence and pattern among Spanishspeaking patients are unknown and have not been compared across regions or with English-speaking patients. Aims The aim of this study was to characterize cognitive impairment in Spanish-speaking patients and compare it with English-speaking patients. Methods The baseline neuropsychological test performance and the prevalence of mild cognitive impairment, defined as a z-score ≤ −1·5 on memory and/or non-memory tests, were evaluated in Spanish-speaking patients in the Secondary Prevention of Small Subcortical Strokes trial. Results Out of 3020 participants, 1177 were Spanish-speaking patients residing in Latin America (n = 693), the United States (n = 121), and Spain (n = 363). Low education (zero-to eightyears) was frequent in Spanish-speaking patients (49-57%). Latin American Spanish-speaking patients had frequent poststroke upper extremity motor impairment (83%). Compared with English-speaking patients, all Spanish-speaking patient groups had smaller memory deficits and larger non-memory/ motor deficits, with Latin American Spanish-speaking patients showing the largest deficits median z-score −1·3 to −0·6 nonmemory tests; ≤5·0 for Grooved Pegboard; −0·7 to −0·3 for memory tests). The prevalence of mild cognitive impairment was high and comparable with English-speaking patients in the United States and Latin American Spanish-speaking patients but not the Spanish group: English-speaking patients = 47%, Latin American Spanish-speaking patients = 51%, US Spanish-speaking patients = 40%, Spanish Spanishspeaking patients = 29%, with >50% characterized as nonamnestic in Spanish-speaking patient groups. Older age [odds ratio per 10 years = 1·52, confidence interval = 1·35-1·71), lower education (odds ratio 0-4 years = 1·23, confidence interval = 0·90-1·67), being a Latin American resident (odds ratio = 1·31, confidence interval = 0·87-1·98), and post-stroke disability (odds ratio Barthel Index <95 = 1·89, confidence interval = 1·43-2·50) were independently associated with mild cognitive impairment.
Introduction
Lacunar strokes are a common stroke subtype, accounting for more than 25% of all brain infarcts. Lacunar strokes are more prevalent in US minorities, particularly Hispanics, and have a higher stroke recurrence rate than in non-Hispanic whites (1) (2) (3) . While the overall short-term outcome is better than for other stroke subtypes, lacunar strokes have an adverse impact on cognitive function and increase the long-term risk of cognitive decline and dementia (4) (5) (6) . In a cohort of English-speaking patients with lacunar stroke, we found that half met criteria for mild cognitive impairment (MCI) with deficits largest on episodic memory and verbal fluency (7) . In addition, a similar pattern of cognitive impairment was present in a systematic review of neuropsychological studies in lacunar stroke cohorts (5) .
Whether the described lacunar stroke-related cognitive impairment pattern generalizes to non-North American non-Englishspeaking populations is unknown. To our knowledge, few data have been published to date on the cognitive outcomes associated with lacunar stroke in Spanish-speaking populations and none on Latin American and US populations specifically (8) .
The overall aim of this study was to describe the baseline cognitive function of the non-English-speaking participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial (9) . Our specific objective was to characterize the cognitive performance in Spanish-speaking participants (SSPs) residing in Latin America and the United States in relation to those of SSPs residing in Spain and English-speaking participants (ESPs) from North America (7) .
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Methods
In this study, we evaluated all SPS3 participants who reported a non-English language as their preferred language (spoken >90%), or as the language spoken >50% of the time at home, with Spanish representing the vast majority. The SPS3 trial was a randomized, multicenter international trial conducted in 81 clinical sites in North America, Latin America, and Spain to determine the optimal treatment to reduce stroke recurrence, cognitive decline, and major vascular events. The eligibility criteria for entry into the trial, published in detail elsewhere (9) , were a symptomatic lacunar infarct confirmed by magnetic resonance imaging (MRI; the index stroke) and no evidence of cortical stroke, cardioembolic disease, or amenable carotid stenosis. Participants with dementia [age-and education-adjusted Mini-Mental State Exam (MMSE) (10) ≤ 24] and those with severe disability due to stroke (modified Rankin scale ≥ 4) (11) were ineligible. Participants were randomized in a 2 × 2 factorial design to both an antiplatelet intervention and a level of blood pressure control. The SPS3 trial was approved by the institutional review boards of all participating centers, and all participants provided informed consent.
At study entry, two-weeks to six-months following the index stroke, all eligible participants underwent assessments of their functional abilities (Barthel Activities of Daily Living Index) (12) and their cognition utilizing tests validated for use in their respective languages. The neuropsychological test (NPT) battery, listed in Supporting Information (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Only the GP test is administered separately for each hand. For all other tests, the 'best' hand was used if the test required use of upper extremity. Administration of any test requiring vision was not done for patients with uncorrected visual impairment. The battery was administered by native local Spanish and French speakers who were SPS3-certified examiners. The certification process and ongoing quality control process have been described in detail elsewhere (7) .
As in the evaluation of the ESP cohort, a classification into not cognitively impaired (NCI) or MCI was performed on the basis of individual test scores, grouped empirically into domains on the basis of principal component analysis (PCA). Impairment on any test was defined as a z-score ≤ −1·5. An NCI classification was assigned if no impairment was present in any cognitive domain. An MCI classification was assigned if there was impairment in at least one domain. MCI was further distinguished into mutually exclusive subtypes: amnestic (impairment in the memory domain), non-amnestic [impairment in a non-memory domain(s)], or multi-domain [impairment in the memory domain plus impairment in a non-memory domain(s)] (7) .
Statistical methods included the conversion of raw NPT into z-scores with reference to the best available normative data, adjusted when possible for relevant factors including age, education, and geographic region (Latin America, United States, Spain). We evaluated test score distributions with the Kolmogorov-Smirnov test and NPT performance abnormalities by comparing the test medians with 0 with the Wilcoxon signed rank test. Demographic and clinical characteristics were compared across SSP groups using chi-square tests, analysis of variance, and Kruskal-Wallis tests as appropriate. To undertake classification into NCI and MCI, we first performed PCA with varimax rotation on the z-scores of all NPT tests with the exception of the CASI and the GP. Because all SSP groups had lower education levels than ESP, PCA was done separately for those with zero-to eight-years of education and those with education ≥ nine years. We then undertook classification into MCI and its subtypes. Multivariable associations with MCI were evaluated with consecutive logistic regression models, first assessing the contribution of sociodemographic factors, then that of pre-stroke and stroke-related factors, and finally the contribution of pre-stroke and strokerelated factors combined. Statistical significance was accepted at the 0·01 level, and all tests were two-sided. Statistical analyses were done using spss 20.0 (IBM, Armonk, NY) and MedCalc 12.1.0 (MedCalc Software, Ostend, Belgium).
Results
Of the 3020 patients randomized into the SPS3 trial, 43% were non-ESPs, while the majority was Spanish-speaking and residing in Spain (n = 366), Latin America including Peru (n = 186), Ecuador (n = 171), Mexico (n = 165), Chile (n = 127), Argentina (n = 45), or in the United States (n = 124). Nearly all had NPT completed at study entry (1177/1184). A small number spoke French (4%) or another language (2%), and resided in the United States or Canada (Fig. 1 ). The French-speaking group resembled the previously described North American ESP cohort (7) in terms of age, education, and cognitive characteristics ( Table 1) . Strokerelated characteristics including stroke localization, clinical syndrome, and extent of residual disability (>85% had a Barthel Index ≥95%, >60% Rankin rating of 0 or 1) were also similar to those found in the ESP ( Table 1 ). The small group speaking other languages did not have the entire NPT battery completed. The French-speaking and group speaking other languages were not considered further in this analysis.
The SSPs from Latin America and Spain were older (means 65 and 64 respectively vs. 60 years; P < 0·001) and with more males (65% and 75% respectively vs. 62%, P < 0·001) compared with the US SSPs. Lower levels of education (zero-to eight-years) were common (∼50%) in all SSP groups (Table 1 ). Just 17% of SSPs from Latin America were motor intact (defined as having no upper extremity weakness, sensory loss, or incoordination on neurological exam) following their qualifying stroke compared with 51% from Spain and 36% of US SSPs (P < 0·001). They also showed more post-stroke disability by the modified Rankin (P < 0·001) and Barthel Index scales (P < 0·001) than other SSPs (Table 1 ).
There were NPT performance differences among SSPs from different regions and between SSPs and ESPs ( Table 2 ). In general, SSPs showed smaller deficits on the CVLT measures, with median z-scores ranging from −0·7 to −0·1, and larger deficits on the GP (median z-score range −5·7 to −2·6). Latin American SSPs performed poorly on all non-memory tests, with large deficits (median z-scores ≤ -1) on BD, SS, and CLOX, even when only motor-intact subjects were considered. US SSPs showed similar deficits, with little or no advantage for motor-intact subjects. Non-memory tests not requiring upper extremity function (i.e. COWA and DS) also showed large deficits (median z-score range −0·7 to −0·6) in Latin American SSPs and US SSPs. By contrast, SSPs from Spain had deficits only on the COWA and CLOX tests, again with little or no advantage for motor-intact subjects. The pattern of lesser memory than non-memory impairment remained for all SSPs, regardless of region, when only subjects with education comparable with the ESP sample (9-12 years and any college) were considered (data not shown).
Because of the confound of education, with some but not all standardized scores adjusted for education, and ∼50% of subjects with zero-to eight-years education among SSPs from all regions, PCA was conducted separately for education groups (Supporting Information Table S2 ). For those with ≥ nine years education, the three-factor solution was identical to that found for ESPs, with an episodic memory, a perceptual/verbal processing, and an executive function factor. For those with zero-to eight-years of educa-tion, the analysis was conducted without the CLOX score because of its strong association with socio-demographic and ethnic factors (24, 25) , and because the norms we used did not adjust adequately for these factors (24) . For those with low education, we identified a two-factor solution, with a memory and a nonmemory factor. The PCA factor solutions were similar across SSP regions for both education groups (Supporting Information  Table S2 ).
Based on these results, for SSP with education ≥ nine years, we utilized the same MCI classification criteria as for the ESPs: specifically, we assigned amnestic MCI if z ≤ −1·5 on at least two CVLT measures; non-amnestic MCI if z ≤ −1·5 on two perceptual/verbal processing tests, and/or z ≤ −1·5 on the executive function (CLOX) test; and multi-domain MCI if criteria for both amnestic and non-amnestic were met. For SSPs with education < nine years, we excluded the CLOX test from the criteria for non-amnestic MCI. With these criteria, 51% of Latin American, 40% of US SSPs, and 29% of SSPs from Spain were classified as MCI (Table 3 ). Less than half of MCI among SSPs had an amnestic impairment pattern compared with two-thirds in ESPs. Irrespective of region, SSPs with MCI showed a clear-cut impairment on the global cognitive tests ( Table 3 , CASI z-score, each region P < 0·001; and MMSE, each region P < 0·05). There were regionspecific associations between MCI status and demographic and stroke-related characteristics including age, gender, education, motor function, previous lacunar stroke, and Rankin score. (11) 60 (10) 64 (11) 62 (11) 62 (10) 61 (9) 63 (13) Male, % (3) 28 (4) 29 (3) 29 (2) 29 (2) 28 (5) 28 (3) MMSE, age, and education adjusted, % ≤25th percentile Research C. Jacova et al. 
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Short-delay cued recall
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Long-delay cued recall Among SSPs, older age, lower education, and being a Latin American resident were independently associated with a higher likelihood of MCI ( Table 4 ). None of the pre-stroke factors contributed additionally to a higher likelihood of MCI, and among stroke-related factors, only Barthel Index <95 did so independently. When pre-stroke and stroke-related factors were combined, only Barthel Index <95 remained in the age-, education-, and region-adjusted model. Given the region-specific pattern of MCI correlates, we also looked at multivariable models of MCI for demographic, pre-stroke, and stroke-related factors for Latin America and Spain separately (the number of US SSPs with MCI was too small compared with the number of variables). Among demographic factors, older age and lower education were associated with MCI in Latin American SSPs but not in Spanish SSPs. No pre-stroke factor, including prior stroke, was associated with a higher likelihood of MCI in either region. Among stroke-related factors, Barthel Index <95 was associated with a higher likelihood of MCI in Latin America, whereas Rankin >0 was associated with MCI in Spain.
Discussion
In this well-characterized cohort of magnetic resonance imaging (MRI)-defined patients with recent lacunar stroke, we evaluated the pattern, prevalence, and determinants of cognitive impairment on NPTs in the non-ESPs in the SPS3 trial, with a particular focus on the Spanish-speaking cohorts residing in Latin America, the United States, and Spain. The SSP cohort differed from the North American ESP cohort on demographic characteristics (older age, lower education, preponderance of male gender). Within the SSP cohort, patients residing in Latin America had a greater proportion of stroke motor syndromes and a higher degree of post-stroke disability. All SSP cohorts, regardless of region of residence, had less impairment on memory measures and more impairment on perceptual and visuo-constructional measures. SSP cohorts differed on severity and prevalence of cognitive impairment, with about half of SSPs from Latin America and the United States but only 29% of SSPs from Spain meeting the criteria for MCI. For all SSPs, as observed previously in the ESP cohort (7), post-stroke functional impairment was the only factor associated with MCI after adjustment for demographic factors.
The finding of proportionately lesser impairment of memory than non-memory functions in the SSP cohorts (in the case of the SSPs from Spain, no impairment) contrasts with our own findings of prominent episodic memory impairments in the ESP cohort (7) and with our systematic review of neuropsychological data on lacunar stroke in European and North American countries (5) . This difference may be related to socio-demographic and/or lacunar stroke differences, and cannot be conclusively evaluated in the absence of NPT data on normal and non-lacunar stroke SSP and ESP controls. From a socio-demographic standpoint, the SSP groups had markedly lower levels of formal schooling compared with the ESP group. Spanish, but not English, norms for the CVLT take into account education (23) , whereas this is not done in norms for either language for the WAIS-III (the source of the majority of non-memory tests). This might have placed the less educated SSP at a relative advantage on memory tests and a relative disadvantage on non-memory tests. However, the mean CVLT raw scores for the SSPs were similar to those for the ESPs, and the education adjustment in the CVLT norms is modest: 7 vs. 9 words for a delayed recall z-score = 0 for a 60-year-old SSP with education = 0-4 years vs. 9-12 years. It is more likely that the cognitive impairment pattern in the SSP groups is related to the greater prevalence of post-stroke motor impairment. Only a small proportion of Latin American subjects were deemed motor intact, and fewer US SSPs were motor intact relative to the ESP cohort. Also, these motor-intact SSPs had a poorer performance on the GP compared with the ESP cohort. Performance of tests of visuoconstruction and perceptual speed could have disproportionately suffered because of these motor limitations in the SSPs. That the cohort of SSPs from Spain had the highest proportion of motor-intact individuals may at least partially explain the relatively low prevalence of MCI observed in that cohort.
The significant motor impairment observed in the Latin American and US SSP cohorts may be related to stroke education and care. Stroke studies from Latin American countries (26) (27) (28) report that medical attention is received only by a small percentage of patients within three-hours of symptoms onset and most not treated by neurologists (27) . Disparities in stroke care among Hispanics in United States have been also reported (2, 29, 30) . These factors may have contributed to greater residual stroke disability in our Latin American SSPs, and in turn shaped the balance of amnestic and non-amnestic impairments.
Our estimates of MCI prevalence in the Latin American (51%) and US SSPs (40%) are consistent with the prevalence for our ESP cohort (47%), and even comparable with other published estimates on all-cause stroke populations, with different MCI criteria. The only Latin American study (Santiago, Chile) on cognitive impairment following stroke estimated its prevalence at 66% after three-months (31) and at ∼40% when individuals with prior cognitive impairment were excluded. These numbers are very similar to those reported in Finland and Australia (62% and 53-58% respectively) (32) (33) (34) and suggest that the frequency of poststroke cognitive impairment is similar across racial-ethnic and geographic groups. As for determinants of MCI, our findings for the SSP cohorts align well with those for our ESP cohort and findings from the Chilean study (31) . Post-stroke functional disability but none of the pre-stroke factors was associated with a higher likelihood of MCI. We failed to find an association between prior stroke and MCI, observed in the ESP cohort, though the SSP cohort was smaller (7) . This analysis of the SPS3 trial is the first to investigate the impact of MRI-confirmed lacunar stroke on cognitive function in a large sample of SSPs from different ethnic groups, including residents from five different Latin American countries, and to allow comparisons with a large sample of North American ESPs, predominantly non-Hispanic whites (9, 35) . Our estimates must be interpreted with some limitations in mind. First, the cohort was part of a randomized clinical trial; therefore, it is likely that our SSP group does not represent the complete spectrum of lacunar strokes in their region of residence. However, the age and vascular risk profile of our cohort is similar to the other lacunar stroke series (36) (37) (38) (39) . Second, different sets of normative data were utilized for different tests, with some but not others adjusting for education, an important confounder in the SSP cohorts. Third, our MCI classifications were based on psychometric criteria rather than on clinical assessment, which would have informed on previous cognitive impairment. We therefore cannot unambiguously attribute all of our MCI cases to the qualifying lacunar stroke and recognize that a proportion may already have been cognitively impaired prior to the study. Fourth, we acknowledge that our geographical SSP groupings are insufficiently granular and do not do justice to the racial-ethnic heterogeneity of the Latin American population. There may be stroke and cognitive features associated with specific Latin American countries or racial groups (e.g. mestizos) that we have missed in our coarse analysis. Finally, as with all neuropsychological testing in which a Research C. Jacova et al.
motor response is required, the exact influence that motor limitations had on our results is unknown.
In summary, our study has shown that half of the patients from Latin America and Hispanics from the United States have cognitive impairment following lacunar stroke. This prevalence is comparable with the ESP cohort. While language of testing is an imperfect surrogate, our findings suggest that racial-ethnic factors do not affect the extent of the impact of lacunar stroke on cognitive function. However, these factors, through a complex mix of socio-demographics and stroke biology, may modulate the expression of the impairment, with non-amnestic rather than amnestic features in SSPs. Because Spanish is the second most spoken language worldwide, there is a clear need for a Spanish NPT battery for the assessment of stroke-related cognitive impairment, with development of culturally and demographically specific norms.
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